Global Human Rabies Immunoglobulin (IM) Market Study 2016-2026, by Segment (ERIG, HRIG), by Market (Category II Exposure, Category III Exposure), by Company (CSL Behring, Grifols , … …)

Published by 99Strategy on 17th November 2019 | Ref: 1463588 | This Product Is In Stock

$1800 | Single User
$3600 | Site License
$3600 | Enterprise License
$1800 | Single User
$3600 | Site License
$3600 | Enterprise License



Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

The global Human Rabies Immunoglobulin (IM) market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):



Demand Coverage (Market Size & Forecast, Consumer Distribution):

Category II Exposure

Category III Exposure

Company Coverage (Sales data, Main Products & Services etc.):

CSL Behring



Sichuan Yuanda Shuyang




Shuanglin Bio

Weiguang Bio

Shanghai RAAS

Bharat Serum


Major Region Market

North America



South America

Middle East & Africa

Table of Contents

Table of Content

1 Industry Overview

1.1 Human Rabies Immunoglobulin (IM) Industry

1.2 Market Segment

1.3 Price & Cost Overview

2 Human Rabies Immunoglobulin (IM) Market by Type

2.1 By Type

2.2 Market Size by Type

2.3 Market Forecast by Type

3 Global Market Demand

3.1 Segment Overview

3.2 Market Size by Demand

3.3 Market Forecast by Demand

4 Major Region Market

4.1 Global Market Overview

4.2 Major Region

5 Major Companies List

5.1 CSL Behring (Company Profile, Sales Data etc.)

5.2 Grifols  (Company Profile, Sales Data etc.)

5.3 Sanofi (Company Profile, Sales Data etc.)

5.4 Sichuan Yuanda Shuyang (Company Profile, Sales Data etc.)

5.5 CNBG (Company Profile, Sales Data etc.)

5.6 Kamada (Company Profile, Sales Data etc.)

5.7 CBPO (Company Profile, Sales Data etc.)

5.8 Shuanglin Bio (Company Profile, Sales Data etc.)

5.9 Weiguang Bio (Company Profile, Sales Data etc.)

5.10 Shanghai RAAS (Company Profile, Sales Data etc.)

5.11 Bharat Serum (Company Profile, Sales Data etc.)

5.12 VINS (Company Profile, Sales Data etc.)

6 Conclusion

Additional Details



Publisher Information


1463588 | 99SGL180Lif201909000024252

Number of Pages


Report Format


Related Reports

Date Published
Price From

Published by The Business Research Company

$1,000 USD

Published by Global Markets Direct

$3,500 USD

Published by Global Data

$400 USD

This report is published by 99Strategy

99Strategy is a well-known independent third party market research consulting company in China.

We are committed to providing professional solutions for corporate strategic decision-making, we operate three business department of market research, custom survey and Investment & financing, mainly covering research report, market survey, competitive survey, market channel investigation, market entry research, consumer research, global market research, business Plan, project feasibility study, PPP project consulting, enterprise IPO and equity investment research, special market solutions, industry plan consulting, company strategic planning, sales consulting, management consulting and other services.

Download Free Report Summary PDF

Global Human Rabies Immunoglobulin (IM) Market Study 2016-2026, by Segment (ERIG, HRIG), by Market (Category II Exposure, Category III Exposure), by Company (CSL Behring, Grifols , … …) | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types


Buy now using our secure payment system.